Testing effectiveness (Phase 2)Study completedNCT01458249
What this trial is testing
An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)
Who this might be right for
Soft Tissue Sarcoma
Eisai Co., Ltd. 52